| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |